Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2007

01-08-2007 | Original Article

Older Patient Perspectives on Long-Term Anxiolytic Benzodiazepine Use and Discontinuation: A Qualitative Study

Authors: Joan M. Cook, PhD, Tatyana Biyanova, Christina Masci, James C. Coyne

Published in: Journal of General Internal Medicine | Issue 8/2007

Login to get access

Abstract

Objective

The objective of the study is to understand patient factors contributing to the chronicity of benzodiazepine use by older adults as a first step in the development of acceptable intervention strategies for taper/discontinuation or prevention of chronic use.

Design

The design of the study consists of qualitative semi-structured patient interviews.

Setting and participants

The participants were 50 anxiolytic benzodiazepine users, 61–95 years of age, recruited through referrals from primary care physicians who practiced in the general Philadelphia, Pennsylvania area.

Results

Many older chronic users have come to rely and psychologically depend on benzodiazepines for their unique soothing properties, attributing to these medications characteristics that extend beyond an ordinary medication, i.e., affording control over daily stress, bringing tranquility, and even prolonging life. Most of the patients denied or minimized side effects and expressed resistance to taper or discontinuation, ranging from subtle reluctance to outright refusal and fear of being left suffering without these medications.

Conclusions

The reluctance of older chronic benzodiazepine users to taper or discontinue use highlights the importance of prevention and early intervention strategies to avoid the development of chronic use. Suggestions for curbing chronic use are presented.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther. 1998;64:684–92.PubMedCrossRef Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther. 1998;64:684–92.PubMedCrossRef
2.
go back to reference Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278:27–31.PubMedCrossRef Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278:27–31.PubMedCrossRef
3.
go back to reference Pomara N, Tun H, DaSilva D, Hernando R, Deptula D, Greenblatt DJ. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull. 1998;34:139–53.PubMed Pomara N, Tun H, DaSilva D, Hernando R, Deptula D, Greenblatt DJ. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull. 1998;34:139–53.PubMed
4.
go back to reference Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc. 1998;46:71–6.PubMed Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc. 1998;46:71–6.PubMed
5.
go back to reference Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158:892–8.PubMed Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158:892–8.PubMed
6.
go back to reference Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc. 2002;50:26–34.PubMedCrossRef Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc. 2002;50:26–34.PubMedCrossRef
7.
go back to reference Oude Voshaar RC, Couvée JE, Van Balkom AJLM, Zitman FG. Strategies to discontinue long-term benzodiazepine use: a meta-analysis. Br J Psychiatry. 2006;189:213–20.CrossRef Oude Voshaar RC, Couvée JE, Van Balkom AJLM, Zitman FG. Strategies to discontinue long-term benzodiazepine use: a meta-analysis. Br J Psychiatry. 2006;189:213–20.CrossRef
8.
go back to reference Voyer P, Cappeliez P, Pérodeau G, Préville M. Mental health for older adults and benzodiazepine use. J Community Health Nurs. 2005;22:213–29.PubMedCrossRef Voyer P, Cappeliez P, Pérodeau G, Préville M. Mental health for older adults and benzodiazepine use. J Community Health Nurs. 2005;22:213–29.PubMedCrossRef
9.
go back to reference American Psychiatric Association Task Force on Benzodiazepine Dependency. Benzodiazepine dependence, toxicity, and abuse. Washington, DC: Author; 1990. American Psychiatric Association Task Force on Benzodiazepine Dependency. Benzodiazepine dependence, toxicity, and abuse. Washington, DC: Author; 1990.
10.
go back to reference Maletta G, Mattox KM, Dyksen M. Guidelines for prescribing psychoactive drugs in the elderly. Geriatrics. 1991;46:40–7.PubMed Maletta G, Mattox KM, Dyksen M. Guidelines for prescribing psychoactive drugs in the elderly. Geriatrics. 1991;46:40–7.PubMed
11.
go back to reference NIH Consensus Development Conference. Drugs and insomnia: the use of medications to promote sleep. JAMA. 1984;251:2410–4.CrossRef NIH Consensus Development Conference. Drugs and insomnia: the use of medications to promote sleep. JAMA. 1984;251:2410–4.CrossRef
12.
go back to reference Llorente MD, David S, Golden AG, Silverman MA. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatry Neurol. 2000;13:150–60.PubMed Llorente MD, David S, Golden AG, Silverman MA. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatry Neurol. 2000;13:150–60.PubMed
13.
go back to reference Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13:243–50.PubMedCrossRef Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13:243–50.PubMedCrossRef
14.
go back to reference Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Gregoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive–behavioural therapy combined with gradual tapering: a randomized trial. CMAJ. 2003;169:1015–20.PubMed Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Gregoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive–behavioural therapy combined with gradual tapering: a randomized trial. CMAJ. 2003;169:1015–20.PubMed
15.
go back to reference Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallières A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry. 2004;162:332–42.CrossRef Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallières A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry. 2004;162:332–42.CrossRef
16.
go back to reference Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment: efficacy of cognitive–behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993;150:1485–90.PubMed Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment: efficacy of cognitive–behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993;150:1485–90.PubMed
17.
go back to reference Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry. 1994;151:876–81.PubMed Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry. 1994;151:876–81.PubMed
18.
go back to reference Cook JM, Marshall R, Masci C, Coyne JC. Physician perspectives on benzodiazepine prescription to older adults: a qualitative study. J Gen Intern Med. 2007;22(3):303–7.PubMedCrossRef Cook JM, Marshall R, Masci C, Coyne JC. Physician perspectives on benzodiazepine prescription to older adults: a qualitative study. J Gen Intern Med. 2007;22(3):303–7.PubMedCrossRef
19.
go back to reference Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983;140:734–9.PubMed Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983;140:734–9.PubMed
20.
go back to reference King M, Gabe J, Williams R, Rodrigo EK. Long term use of benzodiazepines: the views of patients. Br J Gen Psychiatry. 1990;40:194–6. King M, Gabe J, Williams R, Rodrigo EK. Long term use of benzodiazepines: the views of patients. Br J Gen Psychiatry. 1990;40:194–6.
21.
go back to reference Pinsker H, Suljaga-Petchel K. Use of benzodiazepines in primary-care geriatric patients. JAGS. 1984;32:595–7. Pinsker H, Suljaga-Petchel K. Use of benzodiazepines in primary-care geriatric patients. JAGS. 1984;32:595–7.
22.
go back to reference Denzin NK, Lincoln YS. Handbook of qualitative research (2nd ed.). Thousand Oaks (CA): Sage Publications; 2000. Denzin NK, Lincoln YS. Handbook of qualitative research (2nd ed.). Thousand Oaks (CA): Sage Publications; 2000.
23.
go back to reference Patton MQ. Qualitative research & evaluation methods (3rd ed.). Thousand Oaks (CA): Sage Publications; 2002. Patton MQ. Qualitative research & evaluation methods (3rd ed.). Thousand Oaks (CA): Sage Publications; 2002.
24.
go back to reference Linden M, Bar T, Geiselmann B. Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions. Psychol Med. 1998;28:721–9.PubMedCrossRef Linden M, Bar T, Geiselmann B. Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions. Psychol Med. 1998;28:721–9.PubMedCrossRef
25.
go back to reference Barter G, Cormack M. The long-term use of benzodiazepines: patients’ views, accounts and experiences. Fam Pract. 1996;13:491–7.PubMedCrossRef Barter G, Cormack M. The long-term use of benzodiazepines: patients’ views, accounts and experiences. Fam Pract. 1996;13:491–7.PubMedCrossRef
26.
go back to reference Gallo JJ, Lebowitz BD. The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv. 1999;50:1158–66.PubMed Gallo JJ, Lebowitz BD. The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv. 1999;50:1158–66.PubMed
27.
go back to reference Flottorp S, Oxman AD, Havelsrud K, Treweek S, Herrin J. Cluster randomized controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat. BMJ. 2002;325:367–70.PubMedCrossRef Flottorp S, Oxman AD, Havelsrud K, Treweek S, Herrin J. Cluster randomized controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat. BMJ. 2002;325:367–70.PubMedCrossRef
28.
go back to reference Nutting PA, Rost K, Dickinson M, et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern Med. 2002;17:103–11.PubMedCrossRef Nutting PA, Rost K, Dickinson M, et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern Med. 2002;17:103–11.PubMedCrossRef
29.
go back to reference Paredes P, De La Pena M, Flores-Guerra E, Diaz J, Trostle J. Factors influencing physicians’ prescribing behaviour in the treatment of childhood diarrhoea: knowledge may not be the clue. Soc Sci Med. 1996;42:1141–53.PubMedCrossRef Paredes P, De La Pena M, Flores-Guerra E, Diaz J, Trostle J. Factors influencing physicians’ prescribing behaviour in the treatment of childhood diarrhoea: knowledge may not be the clue. Soc Sci Med. 1996;42:1141–53.PubMedCrossRef
Metadata
Title
Older Patient Perspectives on Long-Term Anxiolytic Benzodiazepine Use and Discontinuation: A Qualitative Study
Authors
Joan M. Cook, PhD
Tatyana Biyanova
Christina Masci
James C. Coyne
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 8/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0205-5

Other articles of this Issue 8/2007

Journal of General Internal Medicine 8/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.